Skip to main content

Advertisement

Table 1 Demographics and clinical characteristics of the study cohort (FACEHBI [29])

From: Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)

Variable SCD
Subjects, n 200
Age, years 65.87 (7.23)
Education, years 14.76 (4.73)
Gender, % males 37.5
APOE, % e4 allele carriers 26
Creatinine, mg/dl 0.92 (0.15)
Body mass index, kg/m2 26.64 (4.32)
Hematocrit, % 43.15 (4.93)
FBB-PET SUVR 1.2 (0.15)
FP42/40 0.04 (0.03)
TP42/40 0.09 (0.06)
FP40/TP40 0.44 (0.06)
BP42/40 0.13 (0.09)
FP42/TP42 0.24 (0.21)
  1. Data are shown as mean (SD) unless otherwise specified
  2. APOE apolipoprotein, BP bound peptide, FBB florbetaben(18F), FP free plasma, PET positron emission tomography, SCD subjective cognitive decline, SUVR standardized uptake value ratio, TP total plasma